¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03
±³À°ÀÏÀÚ : 2024-02-03
±³À°Àå¼Ò : ´ë±¸ ±×·£µå È£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ

±³À°ÁÖÁ¦ : Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¿µ³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°ú

´ã´çÀÚ : ³²Á¾È£
¿¬¶ôó : 010-9064-5960

À̸ÞÀÏ : 16njh@naver.com

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:00~13:15 Lifetime management of patients with severe AS ±è¿õ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:15~13:30 Management strategies for heavily calcified coronary artery stenosis ¹ÚÁ¾ÀÏ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:30~13:50 Treatment strategies for coronary bifurcation lesions Á¤¼ºÀ±(¿ï»êµ¿°­)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:50~14:00 Åä·Ð Á¶Çö¼ö(Æ÷Ç×¼¼¸í±âµ¶)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:00~14:15 How to set up TEER for MR in our echo lab È«±×·ç(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:15~14:30 Assessment of true severity of AS: Case-based learning ¼ÕÀå¿ø(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:30~14:50 Advances in assessment of secondary TR ³²Á¾È£(¿µ³²ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:50~15:00 Åä·Ð ÀÌ¿øÀç(¿µ³²ÀÇ´ë)

ÈÞ½Ä 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:00~15:20 ÈÞ½Ä ( )

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:20~15:35 PACs: clinical implication, diagnosis, and treatment ¹Ú±Ôȯ(´ë±¸º¸ÈÆ)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:35~15:50 Indication for conduction system pacing Á¶¹Î¼ö(¼­¿ï¾Æ»ê)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:50~16:10 Single shot technique for rhythm control of AF ±èÈ«ÁÖ(¿¬¼¼ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:10~16:20 Åä·Ð ÀÌ»óÈñ(Æ÷Ç×¼¼¸í±âµ¶)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:20~16:35 Recent Update of New Drugs in HF: Vericiguat and Mavacamten °­»ó¿í(´ë±¸º¸ÈÆ)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:35~16:50 What¡¯s new and what has changed in 2023 ESH HTN guideline? ÀÌÇö¿í(°è¸íÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:50~17:10 Obesity in HF ÃÖ°­¿î(¿µ³²ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:10~17:20 Åä·Ð ¹èÁØÈ£(Æ÷Ç×¼¼¸í±âµ¶)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:20~17:35 Case-based discussion : coronary artery anomaly ±èÈÆÅÂ(Æ÷Ç×¼¼¸í±âµ¶)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:35~17:50 Case-based discussion : coronary artery intervention ±èº´ÁØ(â¿øÇѸ¶À½)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:50~18:10 Case-based discussion : peripheral artery intervention ¹Ú¼¼Çö(´ë±¸º¸ÈÆ)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 18:10~18:20 Åä·Ð ¼ÕÀå¿ø(¿µ³²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ³»½Ã°æ ¾ÆÄ«µ¥¹Ì Åõ¾î (ÀüºÏ) : 2024-02-03
´ÙÀ½±Û ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ Update on MM 2024(ASH review) : 2024-02-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20634 ´ëÀü 2024³â ´ëÀü±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 13 2024-05-10
20633 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18 0 21 2024-05-10
20632 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Á¦ 22Â÷ Ãá°èÁ¤±â½ÉÆ÷Áö¾ö ¹× ÃÑȸ : 2024-05-17 0 7 2024-05-10
20631 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-17 0 5 2024-05-10
20630 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (1ÀÏÂ÷) : 2024-05-17 0 7 2024-05-10
20629 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ¿Â¶óÀÎ_¼­¿ï°æÀÎÁöȸ 276Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-17 0 2 2024-05-10
20628 ¼­¿ï 2024³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-17 0 9 2024-05-10
20627 ´ëÀü ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À° : 2024-05-17 0 15 2024-05-10
20626 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 15 2024-05-10
20625 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõ) : 2024-05-13 0 8 2024-05-10
20624 ¼­¿ï ´ëÇÑ·¹ÀÌÀúÇǺθð¹ßÇÐȸ Á¦46Â÷ Ãá°è Çмú´ëȸ : 2024-05-12 0 9 2024-05-10
20623 ¼­¿ï Á¦2ȸ ´ëÇѽŰæ°úÀÇ»çȸ Ãá°è ÀçÅÃÀÇ·á ½ÉÆ÷Áö¾ö : 2024-05-12 0 21 2024-05-10
20622 ´ë±¸ Á¦54ȸ ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Áõ·ÊÇмú´ëȸ : 2024-05-11 0 12 2024-05-10
20621 °æºÏ 2024³â Á¦28ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¾ö : 2024-05-10 0 8 2024-05-10
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 175 2024-04-30
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷